Loading…
On the Mechanism of Levosimendan-Induced Dopamine Release in the Striatum of Freely Moving Rats
The Ca2+ sensitizer levosimendan (LEV) improves myocardial contractility by enhancing the sensitivity of the contractile apparatus to Ca2+. In addition, LEV promotes Ca2+ entry through L-type channels in human cardiac myocytes. In this study, which was performed using microdialysis, infusion of LEV...
Saved in:
Published in: | Journal of Pharmacological Sciences 2004, Vol.95(3), pp.299-304 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c739t-6fc3adc02975d5ec58c04c8bd9ec8c83b437bcdb3e2c916b9b4476d8e5747dd03 |
---|---|
cites | cdi_FETCH-LOGICAL-c739t-6fc3adc02975d5ec58c04c8bd9ec8c83b437bcdb3e2c916b9b4476d8e5747dd03 |
container_end_page | 304 |
container_issue | 3 |
container_start_page | 299 |
container_title | Journal of Pharmacological Sciences |
container_volume | 95 |
creator | Rocchitta, Gaia Delogu, M. Rosaria Migheli, Rossana Solinas, Luigi Susini, Giuseppe Desole, Maria S. Miele, Egidio Miele, Maddalena Serra, Pier Andrea |
description | The Ca2+ sensitizer levosimendan (LEV) improves myocardial contractility by enhancing the sensitivity of the contractile apparatus to Ca2+. In addition, LEV promotes Ca2+ entry through L-type channels in human cardiac myocytes. In this study, which was performed using microdialysis, infusion of LEV at 0.25 μM for 160 min increased dopamine (DA) concentrations (up to fivefold baseline) in dialysates from the striatum of freely moving rats. Ca2+ omission from the perfusion fluid abolished baseline DA release and greatly decreased LEV-induced DA release. Reintroduction of Ca2+ in the perfusion fluid restored LEV-induced DA release. Chelation of intracellular Ca2+ by co-infusing 1,2-bis (o-amino-phenoxy)ethane-N,N,N′,N′-tetraacetic acid tetra (acetoxymethyl) ester (BAPTA-AM, 0.2 mM) did not affect basal DA release and scarcely affected LEV-induced increases in dialysate DA. In addition, co-infusion of the L-type (Cav 1.1 – 1.3) voltage-sensitive Ca2+-channel inhibitor nifedipine failed to inhibit LEV-induced increases in dialysate DA, which, in contrast, was inhibited by co-infusion of the N-type (Cav 2.2) voltage-sensitive Ca2+-channel inhibitor ω-conotoxin GVIA. We conclude that LEV promotes striatal extracellular Ca2+ entry through N-type Ca2+ channels with a consequent increase in DA release. |
doi_str_mv | 10.1254/jphs.fpe04003x |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_07707841016e49ad943f37794ddc60b1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1347861319324089</els_id><doaj_id>oai_doaj_org_article_07707841016e49ad943f37794ddc60b1</doaj_id><sourcerecordid>66738223</sourcerecordid><originalsourceid>FETCH-LOGICAL-c739t-6fc3adc02975d5ec58c04c8bd9ec8c83b437bcdb3e2c916b9b4476d8e5747dd03</originalsourceid><addsrcrecordid>eNpVUk1vEzEQXSEQLYUrR7Qnbgn-2rV9A7VNiZSqqIDEzfLas4mjXTvYuxH99zjZNIiLx_K8eeN5b4riPUZzTCr2abvbpHm7A8QQon9eFJeYMj4TNRMvz3dML4o3KW0RIgLh-nVxgSvCCUHsslAPvhw2UN6D2WjvUl-GtlzBPiTXg7faz5bejgZseRN2unceykfoQCco3VT5fYhOD-OxcBEBuqfyPuydX5ePekhvi1et7hK8O8Wr4ufi9sf119nq4W55_WU1M5zKYVa3hmprEJG8shWYShjEjGisBCOMoA2jvDG2oUCMxHUjG8Z4bQVUnHFrEb0qlhOvDXqrdtH1Oj6poJ06PoS4VjoOznSgEOeIC4azFMCktpLRlnIumbWmRg3OXB8nrl0Mv0dIg-pdMtB12kMYk6prTgUhNAPnE9DEkFKE9twYI3WwRx3sUYtvt0d7fuWCDyfmsenB_oOf_MiAuwmQs87oLvguS662YYw-y6dMWyfjwCuCEFMIyQrRHLDKykmFKMpjccJElZk-T0zbNOg1nFs9q3D8mawUnY5D-XMqb0JU4DOFmCggG7d3ENWxd14GF8EMWVn3_6DnPaR_Afd9zZE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66738223</pqid></control><display><type>article</type><title>On the Mechanism of Levosimendan-Induced Dopamine Release in the Striatum of Freely Moving Rats</title><source>ScienceDirect Journals</source><creator>Rocchitta, Gaia ; Delogu, M. Rosaria ; Migheli, Rossana ; Solinas, Luigi ; Susini, Giuseppe ; Desole, Maria S. ; Miele, Egidio ; Miele, Maddalena ; Serra, Pier Andrea</creator><creatorcontrib>Rocchitta, Gaia ; Delogu, M. Rosaria ; Migheli, Rossana ; Solinas, Luigi ; Susini, Giuseppe ; Desole, Maria S. ; Miele, Egidio ; Miele, Maddalena ; Serra, Pier Andrea ; Faculty of Medicine ; Department of Pharmacology ; Italy ; London ; UK ; St. Mary's Hospital ; Institute of Anesthesiology ; University of Sassari ; Department of Psychiatry</creatorcontrib><description>The Ca2+ sensitizer levosimendan (LEV) improves myocardial contractility by enhancing the sensitivity of the contractile apparatus to Ca2+. In addition, LEV promotes Ca2+ entry through L-type channels in human cardiac myocytes. In this study, which was performed using microdialysis, infusion of LEV at 0.25 μM for 160 min increased dopamine (DA) concentrations (up to fivefold baseline) in dialysates from the striatum of freely moving rats. Ca2+ omission from the perfusion fluid abolished baseline DA release and greatly decreased LEV-induced DA release. Reintroduction of Ca2+ in the perfusion fluid restored LEV-induced DA release. Chelation of intracellular Ca2+ by co-infusing 1,2-bis (o-amino-phenoxy)ethane-N,N,N′,N′-tetraacetic acid tetra (acetoxymethyl) ester (BAPTA-AM, 0.2 mM) did not affect basal DA release and scarcely affected LEV-induced increases in dialysate DA. In addition, co-infusion of the L-type (Cav 1.1 – 1.3) voltage-sensitive Ca2+-channel inhibitor nifedipine failed to inhibit LEV-induced increases in dialysate DA, which, in contrast, was inhibited by co-infusion of the N-type (Cav 2.2) voltage-sensitive Ca2+-channel inhibitor ω-conotoxin GVIA. We conclude that LEV promotes striatal extracellular Ca2+ entry through N-type Ca2+ channels with a consequent increase in DA release.</description><identifier>ISSN: 1347-8613</identifier><identifier>EISSN: 1347-8648</identifier><identifier>DOI: 10.1254/jphs.fpe04003x</identifier><identifier>PMID: 15272204</identifier><language>eng</language><publisher>Japan: Elsevier B.V</publisher><subject>Animals ; Calcium - metabolism ; Calcium Channels, L-Type - metabolism ; Calcium Channels, N-Type - metabolism ; calcium entry ; Chromatography, High Pressure Liquid ; Corpus Striatum - metabolism ; Dopamine - biosynthesis ; Dopamine - metabolism ; Dopamine Agonists - pharmacology ; Hydrazones - pharmacology ; levosimendan ; Male ; Microdialysis ; Pyridazines - pharmacology ; Rats ; Rats, Wistar ; Simendan ; striatal dopamine ; Time Factors</subject><ispartof>Journal of Pharmacological Sciences, 2004, Vol.95(3), pp.299-304</ispartof><rights>2004 Elsevier B.V.</rights><rights>The Japanese Pharmacological Society 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c739t-6fc3adc02975d5ec58c04c8bd9ec8c83b437bcdb3e2c916b9b4476d8e5747dd03</citedby><cites>FETCH-LOGICAL-c739t-6fc3adc02975d5ec58c04c8bd9ec8c83b437bcdb3e2c916b9b4476d8e5747dd03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1347861319324089$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,4024,27923,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15272204$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rocchitta, Gaia</creatorcontrib><creatorcontrib>Delogu, M. Rosaria</creatorcontrib><creatorcontrib>Migheli, Rossana</creatorcontrib><creatorcontrib>Solinas, Luigi</creatorcontrib><creatorcontrib>Susini, Giuseppe</creatorcontrib><creatorcontrib>Desole, Maria S.</creatorcontrib><creatorcontrib>Miele, Egidio</creatorcontrib><creatorcontrib>Miele, Maddalena</creatorcontrib><creatorcontrib>Serra, Pier Andrea</creatorcontrib><creatorcontrib>Faculty of Medicine</creatorcontrib><creatorcontrib>Department of Pharmacology</creatorcontrib><creatorcontrib>Italy</creatorcontrib><creatorcontrib>London</creatorcontrib><creatorcontrib>UK</creatorcontrib><creatorcontrib>St. Mary's Hospital</creatorcontrib><creatorcontrib>Institute of Anesthesiology</creatorcontrib><creatorcontrib>University of Sassari</creatorcontrib><creatorcontrib>Department of Psychiatry</creatorcontrib><title>On the Mechanism of Levosimendan-Induced Dopamine Release in the Striatum of Freely Moving Rats</title><title>Journal of Pharmacological Sciences</title><addtitle>J Pharmacol Sci</addtitle><description>The Ca2+ sensitizer levosimendan (LEV) improves myocardial contractility by enhancing the sensitivity of the contractile apparatus to Ca2+. In addition, LEV promotes Ca2+ entry through L-type channels in human cardiac myocytes. In this study, which was performed using microdialysis, infusion of LEV at 0.25 μM for 160 min increased dopamine (DA) concentrations (up to fivefold baseline) in dialysates from the striatum of freely moving rats. Ca2+ omission from the perfusion fluid abolished baseline DA release and greatly decreased LEV-induced DA release. Reintroduction of Ca2+ in the perfusion fluid restored LEV-induced DA release. Chelation of intracellular Ca2+ by co-infusing 1,2-bis (o-amino-phenoxy)ethane-N,N,N′,N′-tetraacetic acid tetra (acetoxymethyl) ester (BAPTA-AM, 0.2 mM) did not affect basal DA release and scarcely affected LEV-induced increases in dialysate DA. In addition, co-infusion of the L-type (Cav 1.1 – 1.3) voltage-sensitive Ca2+-channel inhibitor nifedipine failed to inhibit LEV-induced increases in dialysate DA, which, in contrast, was inhibited by co-infusion of the N-type (Cav 2.2) voltage-sensitive Ca2+-channel inhibitor ω-conotoxin GVIA. We conclude that LEV promotes striatal extracellular Ca2+ entry through N-type Ca2+ channels with a consequent increase in DA release.</description><subject>Animals</subject><subject>Calcium - metabolism</subject><subject>Calcium Channels, L-Type - metabolism</subject><subject>Calcium Channels, N-Type - metabolism</subject><subject>calcium entry</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Corpus Striatum - metabolism</subject><subject>Dopamine - biosynthesis</subject><subject>Dopamine - metabolism</subject><subject>Dopamine Agonists - pharmacology</subject><subject>Hydrazones - pharmacology</subject><subject>levosimendan</subject><subject>Male</subject><subject>Microdialysis</subject><subject>Pyridazines - pharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Simendan</subject><subject>striatal dopamine</subject><subject>Time Factors</subject><issn>1347-8613</issn><issn>1347-8648</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVUk1vEzEQXSEQLYUrR7Qnbgn-2rV9A7VNiZSqqIDEzfLas4mjXTvYuxH99zjZNIiLx_K8eeN5b4riPUZzTCr2abvbpHm7A8QQon9eFJeYMj4TNRMvz3dML4o3KW0RIgLh-nVxgSvCCUHsslAPvhw2UN6D2WjvUl-GtlzBPiTXg7faz5bejgZseRN2unceykfoQCco3VT5fYhOD-OxcBEBuqfyPuydX5ePekhvi1et7hK8O8Wr4ufi9sf119nq4W55_WU1M5zKYVa3hmprEJG8shWYShjEjGisBCOMoA2jvDG2oUCMxHUjG8Z4bQVUnHFrEb0qlhOvDXqrdtH1Oj6poJ06PoS4VjoOznSgEOeIC4azFMCktpLRlnIumbWmRg3OXB8nrl0Mv0dIg-pdMtB12kMYk6prTgUhNAPnE9DEkFKE9twYI3WwRx3sUYtvt0d7fuWCDyfmsenB_oOf_MiAuwmQs87oLvguS662YYw-y6dMWyfjwCuCEFMIyQrRHLDKykmFKMpjccJElZk-T0zbNOg1nFs9q3D8mawUnY5D-XMqb0JU4DOFmCggG7d3ENWxd14GF8EMWVn3_6DnPaR_Afd9zZE</recordid><startdate>2004</startdate><enddate>2004</enddate><creator>Rocchitta, Gaia</creator><creator>Delogu, M. Rosaria</creator><creator>Migheli, Rossana</creator><creator>Solinas, Luigi</creator><creator>Susini, Giuseppe</creator><creator>Desole, Maria S.</creator><creator>Miele, Egidio</creator><creator>Miele, Maddalena</creator><creator>Serra, Pier Andrea</creator><general>Elsevier B.V</general><general>The Japanese Pharmacological Society</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>2004</creationdate><title>On the Mechanism of Levosimendan-Induced Dopamine Release in the Striatum of Freely Moving Rats</title><author>Rocchitta, Gaia ; Delogu, M. Rosaria ; Migheli, Rossana ; Solinas, Luigi ; Susini, Giuseppe ; Desole, Maria S. ; Miele, Egidio ; Miele, Maddalena ; Serra, Pier Andrea</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c739t-6fc3adc02975d5ec58c04c8bd9ec8c83b437bcdb3e2c916b9b4476d8e5747dd03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Calcium - metabolism</topic><topic>Calcium Channels, L-Type - metabolism</topic><topic>Calcium Channels, N-Type - metabolism</topic><topic>calcium entry</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Corpus Striatum - metabolism</topic><topic>Dopamine - biosynthesis</topic><topic>Dopamine - metabolism</topic><topic>Dopamine Agonists - pharmacology</topic><topic>Hydrazones - pharmacology</topic><topic>levosimendan</topic><topic>Male</topic><topic>Microdialysis</topic><topic>Pyridazines - pharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Simendan</topic><topic>striatal dopamine</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rocchitta, Gaia</creatorcontrib><creatorcontrib>Delogu, M. Rosaria</creatorcontrib><creatorcontrib>Migheli, Rossana</creatorcontrib><creatorcontrib>Solinas, Luigi</creatorcontrib><creatorcontrib>Susini, Giuseppe</creatorcontrib><creatorcontrib>Desole, Maria S.</creatorcontrib><creatorcontrib>Miele, Egidio</creatorcontrib><creatorcontrib>Miele, Maddalena</creatorcontrib><creatorcontrib>Serra, Pier Andrea</creatorcontrib><creatorcontrib>Faculty of Medicine</creatorcontrib><creatorcontrib>Department of Pharmacology</creatorcontrib><creatorcontrib>Italy</creatorcontrib><creatorcontrib>London</creatorcontrib><creatorcontrib>UK</creatorcontrib><creatorcontrib>St. Mary's Hospital</creatorcontrib><creatorcontrib>Institute of Anesthesiology</creatorcontrib><creatorcontrib>University of Sassari</creatorcontrib><creatorcontrib>Department of Psychiatry</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of Pharmacological Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rocchitta, Gaia</au><au>Delogu, M. Rosaria</au><au>Migheli, Rossana</au><au>Solinas, Luigi</au><au>Susini, Giuseppe</au><au>Desole, Maria S.</au><au>Miele, Egidio</au><au>Miele, Maddalena</au><au>Serra, Pier Andrea</au><aucorp>Faculty of Medicine</aucorp><aucorp>Department of Pharmacology</aucorp><aucorp>Italy</aucorp><aucorp>London</aucorp><aucorp>UK</aucorp><aucorp>St. Mary's Hospital</aucorp><aucorp>Institute of Anesthesiology</aucorp><aucorp>University of Sassari</aucorp><aucorp>Department of Psychiatry</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>On the Mechanism of Levosimendan-Induced Dopamine Release in the Striatum of Freely Moving Rats</atitle><jtitle>Journal of Pharmacological Sciences</jtitle><addtitle>J Pharmacol Sci</addtitle><date>2004</date><risdate>2004</risdate><volume>95</volume><issue>3</issue><spage>299</spage><epage>304</epage><pages>299-304</pages><issn>1347-8613</issn><eissn>1347-8648</eissn><abstract>The Ca2+ sensitizer levosimendan (LEV) improves myocardial contractility by enhancing the sensitivity of the contractile apparatus to Ca2+. In addition, LEV promotes Ca2+ entry through L-type channels in human cardiac myocytes. In this study, which was performed using microdialysis, infusion of LEV at 0.25 μM for 160 min increased dopamine (DA) concentrations (up to fivefold baseline) in dialysates from the striatum of freely moving rats. Ca2+ omission from the perfusion fluid abolished baseline DA release and greatly decreased LEV-induced DA release. Reintroduction of Ca2+ in the perfusion fluid restored LEV-induced DA release. Chelation of intracellular Ca2+ by co-infusing 1,2-bis (o-amino-phenoxy)ethane-N,N,N′,N′-tetraacetic acid tetra (acetoxymethyl) ester (BAPTA-AM, 0.2 mM) did not affect basal DA release and scarcely affected LEV-induced increases in dialysate DA. In addition, co-infusion of the L-type (Cav 1.1 – 1.3) voltage-sensitive Ca2+-channel inhibitor nifedipine failed to inhibit LEV-induced increases in dialysate DA, which, in contrast, was inhibited by co-infusion of the N-type (Cav 2.2) voltage-sensitive Ca2+-channel inhibitor ω-conotoxin GVIA. We conclude that LEV promotes striatal extracellular Ca2+ entry through N-type Ca2+ channels with a consequent increase in DA release.</abstract><cop>Japan</cop><pub>Elsevier B.V</pub><pmid>15272204</pmid><doi>10.1254/jphs.fpe04003x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1347-8613 |
ispartof | Journal of Pharmacological Sciences, 2004, Vol.95(3), pp.299-304 |
issn | 1347-8613 1347-8648 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_07707841016e49ad943f37794ddc60b1 |
source | ScienceDirect Journals |
subjects | Animals Calcium - metabolism Calcium Channels, L-Type - metabolism Calcium Channels, N-Type - metabolism calcium entry Chromatography, High Pressure Liquid Corpus Striatum - metabolism Dopamine - biosynthesis Dopamine - metabolism Dopamine Agonists - pharmacology Hydrazones - pharmacology levosimendan Male Microdialysis Pyridazines - pharmacology Rats Rats, Wistar Simendan striatal dopamine Time Factors |
title | On the Mechanism of Levosimendan-Induced Dopamine Release in the Striatum of Freely Moving Rats |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T10%3A37%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=On%20the%20Mechanism%20of%20Levosimendan-Induced%20Dopamine%20Release%20in%20the%20Striatum%20of%20Freely%20Moving%20Rats&rft.jtitle=Journal%20of%20Pharmacological%20Sciences&rft.au=Rocchitta,%20Gaia&rft.aucorp=Faculty%20of%20Medicine&rft.date=2004&rft.volume=95&rft.issue=3&rft.spage=299&rft.epage=304&rft.pages=299-304&rft.issn=1347-8613&rft.eissn=1347-8648&rft_id=info:doi/10.1254/jphs.fpe04003x&rft_dat=%3Cproquest_doaj_%3E66738223%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c739t-6fc3adc02975d5ec58c04c8bd9ec8c83b437bcdb3e2c916b9b4476d8e5747dd03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=66738223&rft_id=info:pmid/15272204&rfr_iscdi=true |